Egypt-based Multi Apex Pharma is planning to set up a 15k sqm production facility in Saudi Arabia, the company's chairman, Ahmed El Ezaby told the press. El Ezaby didn’t disclose the planned factory’s investment cost, but said that it will be a partnership with Saudi investors in which Egyptians will be the majority shareholders. The facility will house three production lines that would produce three different products of unspecified OSD tablets, liquids and creams.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Banks threaten to look beyond London as windfall tax talk grows
International lenders say more tax could tip the balance as…
EGX30 gained 2.79% in 3Q, but September gave back most of its July-August run, with mid-caps falling the hardest
Small- and mid-cap indices widened their lead over the benchmark…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…